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resumo 
 
 
Recentemente, a necessidade de novas moléculas com atividade 
antimicrobiana aumentou devido ao contínuo aumento do número de bactérias 
patogénicas com resistência aos vários antibióticos disponíveis no mercado. 
Para colmatar esta necessidade, a comunidade científica tem realizado 
esforços na procura de novos microrganismos e dos seus compostos 
bioativos. 
Grande parte do esforço tem sido concentrado em ambientes com condições 
extremas, uma vez que nestes ambientes os microrganismos que os habitam 
têm de ter características muito específicas. As grutas cársicas são 
consideradas ambientes extremos uma vez que a ausência de luz natural 
impede o crescimento de plantas, fazendo com que o ambiente seja 
caracterizado por elevada escassez nutritiva. Juntamente com a elevada 
humidade e a temperatura relativamente baixa e constante, faz com os 
microrganismos que habitam estes ambientes se tornem altamente 
especializados. O facto destes habitats únicos serem pouco estudados, 
nomeadamente no que diz respeito à comunidade bacteriana, torna-os num 
potencial reservatório, tanto de novas espécies como de novos compostos 
antimicrobianos, tal como demonstrado nos poucos estudos existentes. 
Considerando estes factos, os objetivos deste estudo foram: i) obter e 
identificar isolados bacterianos recolhidos em três grutas do Algarve 
nomeadamente, as grutas do Vale do Telheiro, da Senhora e do Ibne Ammar e 
ii) avaliar se os mesmo têm atividade antimicrobiana.  
A partir das amostras recolhidas nas três grutas, foram isoladas 110 estirpes 
bacterianas. Após sequenciação e pesquisa de similaridades em bases de 
dados foi possível verificar que os isolados bacterianos pertencem a três filos, 
nomeadamente Firmicutes, Proteobacteria e Actinobacteria, num total de 19 
géneros diferentes. Em relação à actividade antimicrobiana, os testes foram 
realizados contra seis agentes teste Escherichia coli ATCC 25922, 
Pseudomonas aeruginosa ATCC 27853, Staphylococcus aureus ATCC 25923, 
Enterococcus faecalis ATCC 29212, Aeromonas salmonicida ATCC 33658 e 
Bacillus cereus ATCC 14579. Os resultados revelaram que aproximadamente 
52% dos isolados apresentam atividade antimicrobiana contra, pelo menos, um 
agente teste e que, 10 isolados foram capazes de inibir o crescimento de mais 
de 4 agentes teste.  
Este estudo foi o primeiro a focar a diversidade bacteriana cultivável de grutas 
do Algarve e confirmou que a prospeção de compostos antimicrobianos em 
ambientes subterrâneos poderá ser uma das estratégias para combater o 
problema da resistência aos antibióticos. 
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Recently, the need for new molecules with antimicrobial activity increased due 
to a continuous the increasing number of multi drug resistant pathogenic 
bacteria. To fill this urging need, the scientific community has made a great 
investment in searching for new microorganisms and their bioactive 
compounds. A great part of the effort has been focused in environments with 
extreme conditions, since in these environments the inhabiting microorganisms 
must have very particular features. Karstic caves are considered extreme 
environments due to the nutrient scarcity caused by absence of natural light 
that precludes the growth of vascular green plants. In addition, the relatively 
low and stable temperature and the high humidity levels, force cave dwelling 
microorganisms to become highly specialized. The fact that these unique 
habitats are poorly studied, in particular when considering the bacterial 
community, makes them a potential reservoir for both new species and new 
antimicrobial compounds, as demonstrated in the few existing studies. 
Considering these facts our study aimed at: i) obtain and identify bacterial 
isolates sampled in three caves of Algarve, namely Vale do Telheiro, Senhora 
and Ibne Ammar and, ii) assess their antimicrobial activity.  
From the collected samples of the three caves we are able to isolate 110 
bacterial isolates. After sequencing and searching for homologies in the 
databases it was possible to include the isolates in phyla, namely Firmicutes, 
Proteobacteria and Actinobacteria, in a total of 19 genera. Regarding the 
antimicrobial activity, the tests were performed against six test agents: 
Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, 
Staphylococcus aureus ATCC 25923, Enterococcus faecalis ATCC 29212, 
Aeromonas salmonicida ATCC 33658 and Bacillus cereus ATCC 14579. The 
results revealed that approximately 52% of the bacterial isolates presented 
antimicrobial activity against at least one test agent, and that ten bacterial 
isolates were able to inhibit the growth of more than four test agents. 
This study was the first to focus cultivable bacterial diversity in the Algarve 
caves and confirmed that prospection for new antimicrobial compounds in 
subterranean environments might be one of the strategies for fighting the 
problem of multi drug resistant bacteria. 
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1- Antibiotics 
 
Antimicrobial compounds are chemical substances capable of kill or inhibiting 
the growth of microorganisms. The term is applied to antibacterial, antiviral, 
antifungal and antiparasitic agents. Normally, they are produced by plants, 
animals or microorganisms (Etebu and Arikekpar 2016). Also they are defined as 
low molecular weight organic natural products produced by microorganisms, 
such as secondary metabolites or idiolites, which are active against other 
microorganisms at low concentrations (Demain 2014). 
Antimicrobial compounds are separated in three different categories: natural, 
semi-synthetic and synthetic. Natural compounds are originally extracted from 
plants, fungi, microorganisms and animals. Semi-synthetic compounds are 
natural compounds that have been chemicallly modified to minor toxicity effects 
or enlarge effectiveness rates. Synthetic compounds are totally chemically 
engineered and revealed to be more effective than natural or semi-synthetic 
agents (Etebu and Arikekpar 2016). 
The antibiotic discovery remote to the beginning of 20th century with the 
discovery of arsphenamine (Salvarsan or compound 606) by Paul Ehrlich (Bosch 
and Rosich 2008). This drug has activity against the bacterium Treponema 
pallidum, which cause syphilis infection disease. In 1928 Alexander Fleming 
discovered Penicillin and, after many years of optimizing the producing process, 
this drug was used to treat many Gram-positive bacterial infections (Bosch and 
Rosich 2008). Some years later, Selman Waksman isolated streptomycin 
(Hathaway et al. 2014). The drug was applied to treat gram positive and negative 
bacteria and was the first treatment for tuberculosis (Bosch and Rosich 2008). 
Between 1945 and 1960, most of the antibiotics currently applied were 
discovered, being this period known as “Golden Era of Antibiotic Discovery”. 
Since then the discovery  of new antibiotics was significantly slowed down and a 
new problem has emerged, the appearance of multi-drug resistant bacteria 
(Lewis 2017). 
 
1.2- Classes, modes of action and examples 
 
Antibiotics have several mechanisms of action on target cells. Their principal 
action modes depend on the target organelle and generally include inhibition of 
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vital cell processes such as protein synthesis, nucleic acid synthesis, cell wall 
synthesis and other metabolic pathways (Dowling, Dwyer, and Adley 2017). 
The most relevant antibiotics produced by microorganisms include the β-
lactams, tetracyclines, aminoglycosides, chloramphenicol, macrolides and 
glycopeptides (Etebu and Arikekpar 2016).  
The class of β-lactam antibiotics is the oldest class of antibacterial agents and 
it includes penicillin and derivates, monobactms, carbapenems and 
cephalosporins (Etebu and Arikekpar 2016). All the members of β-lactam 
antibiotics contain a β-lactam ring in their molecular structure. These antibiotics 
irreversibly inhibit the activity of transpeptidase, an essential enzyme for cell wall 
synthesis.  
Tetracyclines were discovered in the 1940s and are broad spectrum 
antimicrobial agents used to treat Gram positive and negative bacteria, 
mycoplasmas and protozoan parasite. They inhibit protein synthesis by 
interfering with amino acid transfer preventing the association of aminoacyl-tRNA 
with the bacterial ribosome (Chopra and Roberts 2001). 
Aminoglycosides are a class of antibiotics that act on the inhibition of protein 
production, altering cell wall permeability and causing genetic code to misread by 
rRNA binding to 30S subunit. They are particularly important for treating Gram-
negative infections, mainly caused by aerobic bacteria. Neomycin, streptomycin 
and kanamycin are examples of antibiotics included in this group and they were 
isolated from Streptomyces spp., Micromonospora spp. and Bacillus spp. 
(Demain 2014).   
Chloramphenicol is bacteriostatic and was firstly isolated from Streptomyces 
venezuelae but today is produced artificially due to his simple structure (Demain 
2014). It acts by inhibition of protein synthesis by blocking elongation of 
polypeptide chain. 
Macrolides were first isolated in 1952 as a metabolic product of soil fungus 
Saccharopolyspora erythraea. They are often administrated to peniciin allergic 
patients and act by effectively inhibiting protein production. The compound binds 
to bacterial ribosome and block the addition of amino acids to polypeptide chain 
(Etebu and Arikekpar 2016). 
Glycopeptides are the most relevant class of antibiotics applied to the 
treatment of aggressive infection caused by Gram-positive bacteria, such as 
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enterococci and MRSA- Staphylococcus aureus. Vancomycin is one of the 
antibiotics belonging to this group and basically it interferes with cell wall 
production in Gram-positive bacteria (Kang and Park 2015). 
 
 
2- Antibiotic resistance 
 
Antibiotic resistance is defined as the capacity of bacteria to resist the effects 
of an antibiotic to which they were previously sensitive, living and growing in his 
presence. This scenario is a consequence of more than 70 years of widespread 
use of antibiotics that allowed the evolution of pathogenic resistant bacteria and 
lead to the inefficacy of most of the available antibiotics being. From a clinical 
point of view an infection by an antibiotic resistant bacterium can present severe 
health problems, namely if the available antibiotics are no longer effective 
(Alnahdi 2014) 
Drug resistance genes can be passed from one bacterium to another through 
several mechanisms (figure 1). Bacteria can acquire external DNA via 
transposons, plasmids, bacteriophages or naked DNA. Some transposons 
containing integrons can assemble different antibiotic genes or other gene 
cassettes, resulting in spreading of multiple resistance mechanism at once. Also, 
chromosomal genes can be transferred through a process named transformation: 
a bacterium collects naked DNA discharged by another bacterium (Levy and 
Bonnie 2004). Although resistant genes prevailed in clinical environments, 
scientists have discovered that resistance genes are a naturally occurring 
process which is encoded for by ancient microbial genes (Aminov 2010). 
Therefore, this natural process was amplified since the beginning of the Antibiotic 
Era. There are two components that cause drug resistance: the antimicrobial 
compound and the genetic resistance determinant (Levy 2002). The antimicrobial 
compound selects the bacteria that are resistant while the genetic resistance 
determinant in bacteria is selected by the antimicrobial  compound (Levy and 
Bonnie 2004). When these two conditions are present in the environment or in a 
host, antimicrobial selection favours proliferation of resistant genes and host to 
another bacteria or geographic location (Levy 2002). 
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In our modern world millions of kilograms of antimicrobial agents are 
disseminated each year to treat people, animals and crops globally, and none of 
the classes of antibiotics escape a resistance mechanism (Levy and Bonnie 
2004). 
 
 It is expected that appearance of resistance against new antimicrobial 
compounds continues to be a major problem. Additionally, in clinical 
environments, there has been an increasing number of novel resistance genes 
mainly because of the uncontrolled use of antibiotics in the past years. 
Nowadays, there are several strains that are resistant to all the available 
antibiotics, designated multidrug-resistant bacteria (MDR) or “superbugs”. For 
example, methicillin-resistant (MRSA) Staphylococcus aureus, MDR 
Acinetobacter baumannii and numerous strains of extended-spectrum β-
Figure 1 - Mechanisms of bacterial gene transfer (Source: Levy and Bonnie 2004). 
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lactamase (ESBL)-producing such as Escherichia coli, Salmonella spp., 
Pseudomonas aeruginosa and Klebsiella pneumoniae.  For instance, MRSA S. 
aureus is the main cause of nosocomial and society-acquired infections it causes 
bloodstream infections, pneumonia and surgical-site infections, and is resistant 
to methicillin and other penicillin class antibiotics (Alnahdi 2014).  
In two studies conducted in Lechuguilla cave (Bhullar 2011), researchers 
compared surperficial and subterranean isolates of Paenibacillus spp. and found 
that non-pathogenic bacteria contain several different genes orthologous and 
even similar to those that are present in pathogenic bacteria. More specific, a 
single studied bacterial strain was resistant to 26 of 40 tested antibiotics, 
containing 12 orthologous of known resistance families and 5 new mechanisms 
of resistance (Pawlowski et al. 2016). 
 
 
3- New antimicrobial compounds prospection 
 
In search for new therapeutic drugs, there is a huge need for novel and more 
effective antimicrobial compounds to combat the persistent appearance of multi-
drug resistant pathogens (Monciardini et al. 2014). Natural products constitute 
the major structural and chemical diversity that cannot be compared to any 
synthetic compound’s library of small molecules. They are a continuing 
inspiration to novel discoveries in scientific areas such as chemistry, biology and 
medicine. Also, natural products are evolutionarily optimized as drug-like 
molecules and remain the best sources of therapeutic drugs (Newman and Cragg 
2012).   
In order to increase the odds on prospection of antimicrobial compounds, some 
authors suggest that looking in less studied and neglected habitats may be a 
good strategy to find novel compounds (Monciardini et al. 2014). Also, many of 
the available antibiotics were isolated from microorganisms namely, bacteria and 
fungus (Etebu and Arikekpar 2016). Since only a small fraction of microorganisms 
has been screened for the production of bioactive molecules, there is, in principle, 
a rich, unexplored source for specialized microorganisms and consequently their 
metabolites (Monciardini et al. 2014). This has a special interest in exploring new 
microbial taxa, different niches and poorly explored habitats such as 
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subterranean environments. As an example, a larger part of the discovered 
antimicrobial compounds has been isolated from terrestrial environments, but 
recently almost 23% of the new bioactive molecules were isolated from 
unexplored marine niches such as sediments (Cragg and Newman 2014), 
sponges (Anand et al. 2006) or the deep-sea (Anand et al. 2006).  
Additionally, the subterranean environment could be considered an extreme 
habitat due the oligotrophic conditions that it features. The lack of nutrients makes 
the life in caves intolerable for most of the microorganisms (Barton 2006). 
Microorganisms living in extreme conditions have to be considered a good source 
to find new bioactive compounds (Wilson and Brimble 2009)  This make the 
subterranean environment the perfect location to increase the odds on 
prospection for new antimicrobial compounds. 
 
 
4- Caves as a suitable environment for prospecting 
microorganisms with novel antibiotic compounds 
 
4.1- Caves  
Caves are defined as natural spaces below the Earth’s surface that are 
accessible to human entrance (Gillieson 1996). Speleogenesis is any natural 
process that hollow out of rock resulting in the formation of natural caves. These 
processes include dissolution, volcanic activity, mechanical weathering  or the 
melting of glacial ice (Engel 2010).  
The classification of natural caves is mainly based on the type of host solid rock 
where they were developed and on the method of formation. Concerning the 
geological constitution, the most common caves are those formed in limestone, 
calcareous and basaltic rocks. There are also other type of caves such as 
gypsum, granite, talus, quartzite, ice and sandstone, but are usually less 
extensive and less frequent (Ford and Williams 2013).  
Regarding the formation process there are three main primary mechanisms: 
dissolution by carbonic acid, the dissolution driven by sulfuric acid and the cooling 
of lava from volcano eruption. The typical limestone caves are formed when water 
passes through the soil, taking in carbon dioxide and forming a dilute solution of 
carbonic acid. As this water infiltrates the ground, the direct contact with 
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limestone makes the water dissolve calcium carbonate. When the water reaches 
the cave, carbon dioxide is released, allowing the formation of stalactites and 
stalagmites (Engel 2010). Altamira cave in New Spain and Krubera cave, the 
deepest cave in the world, in Georgia, are classical examples of limestone caves. 
Cave formation driven by sulfuric acid occurs when hydrogen sulphide 
progresses along fissures and until reaches the oxygenated zone. At the 
oxygenated zone, some forms of sulfuric acid can dissolve limestone. Carlsbadd 
caves and Lechuguilla caves are examples of sulfuric acid cave type. Lastly, lava 
cave tubes occur when during a volcano eruption the superficial molten lava cools 
down faster than the interior. When the eruption stops, the flowing lava solidifies 
leaving the interior conduit empty. One of such examples is the Kazumura in 
Hawai being the longest lava tube in the world and  also in Azores the lava tube 
named Torres cave (Northup and Lavoie 2001). 
 
4.1.1- Cave zonation 
 
Caves are zonal environments with zonation in caves being defined based on 
several physical parameters such as the amount of light, moisture, air flow, gas 
concentration and evaporitic power of the air (Ghosh, Kuisiene, and Cheeptham 
2016). Based on these parameters, we can define five different zones: entrance, 
twilight, transition, deep and stagnant air zones. 
Figure 2 - Schematic representation of cave zones. (Source: Ghosh, Kuisiene, & Cheeptham, 
2016). 
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 The entrance and twilight zones are the most influenced by surface. These 
areas are the limit for growth of vascular green plants once sun light can reach 
these zones. Transition zone is characterized by total darkness and some 
variation regarding the other abiotic parameters (fluctuations in air flow, moisture 
and potential evaporation rates). At the deep cave zone, the physical parameters 
remain very stable: air is saturated with water vapor and the substrate is 
constantly moist. The stagnant air zone is not always present and is characterized 
by restriction in gas exchange causing the stagnation of cave atmosphere 
(Lurdes and Dapkevicius 2013). 
 
 
4.1.2- Karstic caves  
 
Karstic landscape is characterized by closed depressions, deep groundwater 
circulation, dolomitic limestone, evaporitic terrains and caves (Ford and Williams 
2013).  Karstic landscapes are formed by dissolution of the rock mainly limestone. 
But dissolution can occur in other type of rock particularly carbonates such as 
dolomite, in evaporites such as gypsum, in silicates, some basalts and granites.  
Consequently, the superficial area of karst terrain (epikarst) is dry and 
development of dissolution morphologies is very characteristic. These features 
promote rapid infiltration of water and cause the formation of polja, swallow holes 
and caves.  
Figure 3 - Karst regions of the world (Source: Ganter, 2018). 
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Around 15% of world surface is karst and in figure 3 we can see the distribution 
of karstic terrains worldwide. We can see significant areas in Asia, Europe and in 
the American continent. Some of these areas and formations are very touristic 
but a large part remans unexplored (Hollingsworth et al. 2007).  
In Portugal the karstic terrain is concentrated in the mainland (figure 4), being 
the most relevant karst areas the Estremenho (Serra de Aire e Candeeiros), 
Arrábida, Sicó-Condeixa-Alvaiázere, Montejunto and Algarve. These areas are 
Jurassic limestone and dolomites and caves are found from the costal territory 
(Arrábida) to higher points like Serra de Montejunto (Reboleira et al. 2011) 
 
 
 
Figure 4 - Karstic regions of Portugal. (1- Dine; 2- Vimioso; 3- Cantanhede; 4- Mealhada; 5- Boa 
Viagem;6- Sicó-Condeixa e Alvaiázere; 7- Estremenho; 8- Cesaredas; 9- Montejunto; 10- 
Península de Lisboa; 11- Arrábida; 12- Estremoz-Cano; 13- Adiça-Ficalho; 14- Algarve.) (Source: 
Reboleira et al. 2011).  
 
 
4.2- Cave bacteria  
 
Study of cave bacteria is relatively recent and consequently limited. The 
ecological role of these organisms in subterranean environments isn’t entirely 
determined yet, but some groups have already been related to some functions. 
Regarding the ecological role of cave bacteria two functions were predicted by 
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scientists: bacteria as primary producers and bacteria altering cave shape. For 
example, some sulphur-oxidizing bacteria were associated with gypsum and 
carbonate formation (Cacchio et al. 2004). Also, chemolithotrophic bacteria are 
able to gain energy by using sulphur molecules as electron donors, acting like 
primary producers. Another example is ammonium and nitrite oxidizing bacteria 
that were associated with saltpeter formation (Kumaresan et al. 2014). These 
bacteria can convert ammonia into nitrate allowing deposition of saltpeter and 
modelling the cave shape (Barton 2006).  
As for diversity, the phylum Proteobacteria is one of the most representative 
and members of all the five sub-groups were found in cave environments. Also, 
members of Actinobacteria, Firmicutes, Bacteroidetes, Flavobacteria and 
Nitrospira were detected in all three types of caves: limestone, granitic and lava 
(Tomczyk-Żak and Zielenkiewicz 2016). To study diversity of cave bacteria there 
are two main approaches: cultivation methods and molecular phylogenetic 
analysis (Barton 2006). Cultivation approaches are very limited, however having 
bacterial strains in laboratory allows investigators to perform several tests, adjust 
cultivation conditions and extract bioactive molecules produced by these 
microorganisms (Gálvez et al. 1993; Lamprinou et al. 2015). Nonetheless, 
scientists believe that 99% of the existent bacteria are non-cultivable (Cacchio et 
al. 2004). Molecular approaches allow an overall view of the diversity and also 
allow the prediction of some ecological roles of distinct bacterial groups in which 
cultivation methods are ineffective (Lurdes and Dapkevicius 2013). 
    
4.2.1- Cultivable diversity of cave bacteria 
Cultivation methods can be very limited for having a real picture of bacterial 
diversity in caves, mainly because there are no standard methodologies for 
cultivation of this type of cells and the wide variety of studies in this area. The 
type of samples is the primary variable in studies on cave bacteria. Samples could 
range from soil and sediment (Nakaew, Pathom-aree, and Lumyong 2009), rock 
walls (Tomova et al. 2013), moonmilk (Portillo and Gonzalez 2011), biofilms 
(Borsodi et al. 2012), coloured spots on walls (Porca et al. 2012) to Palaeolithic 
paintings (Bastian et al. 2010). The culture media employed are very variable too, 
as well as the incubation period, temperature and pH. Studies also have different 
aims and some only intent to isolate a fraction of bacterial diversity. Table 1 
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summarizes some studies carried out in caves and specify the genera found in 
those studies. 
Table 1- Studies on cultivable bacteria isolated from caves. 
 
Type of sample Identified genera Reference 
Moonmilk 
speleothem, water of 
underground lake 
Streptomyces; Nocardia (Axenov-Gribanov et al. 
2016) 
Soil samples Actinomadura; Actinoplanes; 
Gordonia; Microbispora; 
Micromonospora; Nocardia; 
Nonomureae; Saccharopolyspora; 
(Niyomvong et al. 
2012) 
Several types of 
samples 
Streptomyces; Nocardia; 
Rhodococcus; Nocardioides 
(Groth et al. 1999) 
Sediments 
 
Bacillus; Pseudomonas; 
Brevibacillus; Enterococcus; 
Paenibacillus; Microbacterium; 
Phenylobacterium; Caulobacter; 
Sphingomonas; Exiguobacterium; 
Massilia; Psychrobacter; 
Carnobacter; Staphylococcus 
(Yasir 2018) 
Soil samples Streptomyces (Belyagoubi et al. 2018) 
Guano deposits, log 
and twig deposits, 
leaf litter deposits 
 
Brevundimonas; Bacullis 
 
(Karkun, Patle, and 
Verna 2014) 
Biofilm samples Geothermobacterium; Levilinea; 
Nitrospira; Ignavibacterium; 
Desulfovibrio; Anaeromyxobacter; 
Thermolithobacter; Acidothermus; 
Lentzea; Cytophaga; 
Methylacidiphilum 
(Borsodi et al. 2012) 
Soil and clay from 
cave walls, 
sediment, 
speleothems, 
drinkable water and 
coloured spots in 
cave walls 
Micrococcus¸Bacillus (Klusaite et al. 2016) 
Rock walls Enterobacter; Pseudomonas; Serratia; 
Bacillus; Micrococcus; 
Sphingobacterium; Acinetobacter; 
Obesumbacterium; Arthrobacter 
Stenotrophomonas; Comamonas 
(Tomova, Lazarkevich, 
Tomova, Kambourova, & 
Vasileva-Tonkova, 2013) 
Yellow, grey, pink 
and white cave silver 
Paenibacillus; Pseudomonas; 
Lysobacter; Sphingomonas; 
Bosea; Agrobacterium; 
Micrococcus; Bacillus; Oerskovia; 
(Velikonja, Tkavc, and 
Pašić 2014) 
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Arthrobacter; Streptomyces; 
Aerococcus 
 
Soil samples Streptomyces; Micromonospora; 
Spirillospora; Saccharothrix; 
Nonomuraea; Actinocorallia; 
Pseudonocardia; Catellatospora; 
Microbispora 
 
(Nakaew, Pathom-aree, 
and Lumyong 2009) 
Moonmilk samples Agromyces; Amycolatopsis; 
Kocuria; Micrococcus; 
Micromonospora; Nocardia; 
Streptomyces; Rhodococcus 
 
(Nakaew, Pathom-aree, 
and Lumyong 2009) 
 
 
Prospecting new antimicrobial compounds from cave bacterial isolates 
Studies on antimicrobial activity of cave isolates has increased in the past 
decade (Yasir 2018; Patel et al. 2014; Bredholdt et al. 2007; Yücel and Yamaç 
2010). Many investigations were conducted in cave environments due to the 
abiotic pressure that is a feature in caves. Together with the relatively low and 
constant temperature, absence of light makes impossible the growth of vascular 
green plants and consequently the amount of organic matter is very low. At these 
circumstances, microorganisms need to be adapted to limitations on available 
nutrients closed to starvation (Barton and Northup 2007). At the same time, 
bacteria need to control the growth of other bacterial groups producing different 
types of antimicrobial molecules that could be used as antibiotics.   
Methods for evaluating antimicrobial activity aren’t unanimous and each 
investigation employs different methodologies. For example, a study conducted 
in two caves of Pakistan used confrontation bioassay with paper filter discs to 
evaluate the antimicrobial potential of their isolates (Yasir 2018). In contrast, 
another study that evaluated the antimicrobial capacity of Streptomyces spp. 
isolated from Grotte des Collemboles (Springtails’Cave) in Belgium choose 
cross-streak method (Maciejewska et al. 2016).  
Antimicrobial activity of cave isolates has been studied in several caves around 
the world. For instance, from a collection of 47 actinomycetes isolated from 
Chaase cave in Algeria, all showed antimicrobial activity against at least one test 
agent and 61,7% were active against S. aureus (Belyagoubi et al. 2018). In other 
study performed in two caves in the Hindu Kush mountain, 86 isolates were 
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tested against Salmonella thypimurius and S. aureus and the results revealed 
that 15 and 30 were respectively active against these test agents. Also, six 
isolates were active against both pathogens (Yasir 2018). In an investigation 
conducted in Krubera-Voronja Cave, it was possible to isolate two different 
compounds extracted from two Bacillus strains, suggesting that bioactivity assays 
should be performed using bacterial isolates from Firmicutes phylum contrasting 
with of focus given by many authors for Actinobacteria (Klusaite et al. 2016). 
 
 
5- Goals and structure of the dissertation 
 
Considering the necessity for new antibiotics and the increased potential for 
obtaining these from microorganisms growing in relatively unexplored 
environments, such as caves, the main objectives of this dissertation were to:  
i) Isolate cultivable bacteria from Algarve caves and identify them based on 
16S rDNA gene sequence; 
ii) Screen bacterial isolates for antimicrobial activity against six test agents: 
Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, 
Staphylococcus aureus ATCC 25923, Enterococcus faecalis ATCC 29212, 
Aeromonas salmonicida ATCC 33658 and Bacillus cereus ATCC 14579. 
 
The present dissertation is composed of three chapters. The first is of 
introductory nature, providing information over the various aspects relevant for 
understanding the global perspective of this thesis. The second chapter 
comprehends the practical approach in order to attain the objectives of this 
dissertation, and the final chapter (III) consists of the final remarks, where all of 
the results obtained are further discussed and future perspectives are addressed. 
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1- Introduction 
In the past decades, there has been an increasing demand for new antibiotics 
due to the ability of microorganisms to develop resistances against existing 
antibiotics. The World Health Organization (WHO) stated global health 
emergency to the current multiplying resistance strains and the lack of new 
antibiotic to fight them (World Health Organization 2014). Along with this, 
scientific community dedicate their attention to explore neglected and extreme 
environments to enlarge natural product drug discovery (Onaga 2001). For 
example, Vollú et al. (2014) found that 13,7% of the isolates of spore-forming 
bacteria isolated from Antarctic soil samples were able to inhibit the growth of 
MRSA. Also, another study conducted in the Thar Desert revealed a remarkable 
antimicrobial activity of an yellow pigment extracted from Streptomyces 
hygroscopicus subsp. ossamyceticus (Selvameenal, Radhakrishnan, and 
Balagurunathan 2009).  
Caves are considered extreme environments for the occurrence of life forms. 
The reunion of severe abiotic conditions such as total darkness, thermal stability 
and high humidity (98-100%) results in an absence of primary producers and 
consequently starved conditions (Barton 2006). Also, cave environments have 
very low organic carbon input since energy enters the cave in a very limited way, 
only via entrances, sinkholes, dripping waters or underground hydrology (Diana 
E Northup and Lavoie 2001). These circumstances make caves only capable of 
sustaining highly specialized microorganisms and their metabolic pathways are 
augmented over the bioactive molecules production inhibiting the growth of other 
microorganisms (Lurdes and Dapkevicius 2013). For instance, from a cave soil 
sampled collected in the mountain of Miroc in Serbia, Stankovic and her 
colleagues isolated a red-pigment producing bacterium. The tests conducted on 
the deep red pigment revealed antimicrobial activity against Bacillus and 
Micrococcus species and Candida albicans, but also antioxidative and UV-
protective properties (Stankovic et al. 2012). 
One of the most common types of caves are karstic caves. They are 
extensively distributed worldwide, many of them are yet to be discovered or have 
hardly been accessed, although other caves with pre-historic paintings have 
received substantial attention (Groth et al. 1999; Tomova et al. 2013).  Despite 
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their historically importance, our knowledge on the microbiology diversity of caves 
is still scarce (Tomova et al. 2013). Namely in the Portuguese territory, despite 
the existence of large karstic massifs encompassing the majority of the existing 
caves systems, there are no studies concerning microorganisms. 
Studies on cultivable diversity of cave bacteria encompasses members of 
Proteobacteria, Actinobacteria and Firmicutes groups (Tomczyk-Żak and 
Zielenkiewicz 2016). Current molecular techniques revealed a great 
microbiological diversity in cave environments, surprisingly high compared to 
what was expected given the amount and complexity of nutrients available in 
subterranean environments (Wu et al. 2015). A metagenomic study performed in 
Villa Luz cave revealed a surprisingly diversity encompassing seven phyla 
namely, Acidobacteria, Actinobacteria, Bacteroidetes, Chloroflexi, Firmicutes, 
Ignavibacteria and Proteobacteria (D’Auria et al. 2018). Besides the diversity 
studies, scientists have also dedicated their time to develop new techniques to 
discover unknown secondary metabolites, especially those with antimicrobial 
properties (Donadio et al. 2002).  
There are some studies that have already evaluated the antimicrobial activity 
of bacterial isolates inhabiting subterranean environments, revealing a great 
potential. Such has reinforced the ideia that there is a great potential on 
prospecting of novel bioactive compounds in these habitats (Niyomvong et al. 
2012; Rule & Cheeptham 2013; Nareeluk Nakaew et al. 2009).  
Considering the constant need for new antibiotics, the potential of cave 
habitats for prospection of novel compounds, and the lack of studies in the 
Portuguese territory, the main aim of this study was to isolate bacteria from 
Algarve caves, identify them, and verify if any are capable of presenting 
antimicrobial activity against six test agents: Escherichia coli ATCC 25922, 
Pseudomonas aeruginosa ATCC 27853, Staphylococcus aureus ATCC 25923, 
Enterococcus faecalis ATCC 29212, Aeromonas salmonicida ATCC 33658 and 
Bacillus cereus ATCC 14579. 
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2- Materials and Methods 
 
2.1- Sampling site 
Algarve is the southest region of mainland Portugal. The region has one of the 
most important karstic massifs with more than fifty natural caves known. 
This study was conducted in three caves of the Algarve region: Ibne Ammar, 
Vale do Telheiro and Senhora (see figure 1). The Ibne Ammar cave is located in 
Lagoa city, on the left side of the Arede river. The cave has many entrances and 
some galleries are flooded due to the tide effect. As for Vale do Telheiro cave it 
is one of the largest caves in the region and it’s located in Loulé city. Senhora 
cave is part of a geological monument named Cerro da Cabeça, located in Olhão. 
Figure 1 - Location of Algarve caves (1- Ibne Ammar cave; 2- Vale do Telheiro cave; 3- Senhora cave). 
The access of all the sampled caves was very difficult and requires 
speleological support material. All the galleries selected for sampling had no 
evidences of human presence in order to assure that bacterial samples were 
really from subterranean environments. Also, no major sources of organic matter 
were observed in all the three caves. In the entrance zone we are able to see 
some superficial roots and very few bats (one or two), but at deeper galleries, 
where samples were taken, we could only see insects. The entrance areas 
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present superficial roots and bats, but in the deeper galleries, where samples 
were taken, only invertebrates were observed. 
 
2.2- Sampling, isolation and culture conditions 
Samples were collected by gently passing on cave walls with sterile cotton 
swabs. Immediately after, the samples were inoculated on Petri dishes with TSA 
and PCA media and falcon tubes with TSB, and kept refrigerated until arrival to 
the laboratory. At the laboratory, samples on TSB tubes were transferred to Petri 
plates with TSA. All samples were kept at room temperature with no light. When 
bacterial growth was evident, isolation of all morphological different colonies was 
carried out for a new petri plate with TSA media. Pure cultures were maintained 
in microtubes (in triplicates) in a solution of TSB with 20% of glycerol, at –20⁰C.   
 
2.3- Amplification of 16S rDNA gene by PCR and sequencing 
To allow the sequencing analysis, twenty-four hours broth cultures of all 
isolates were prepared for DNA extraction using GF1 bacterial DNA extraction kit 
(Vivantis Technologies). Genomic DNA was used as template DNA for 16S gene 
PCR amplification. Reactions of 25 µL containing: The PCR reactions were 
performed in 25 µL reactions containing 0.2 µM each primer (27F and 1492R) 1x 
PCR buffer, 0.2 mM each dNTP, 2 mM MgCl2,1U Taq polymerase and 2 µl of cell 
lysate as template DNA. The reaction mixture was incubated in a Thermal Cycler 
(Bio-Rad) with an initial denaturation step at 95 °C for 5 min followed by 30 cycles 
of 95 °C for 30 s, 55 °C for 30 s, and 72 °C for 60 s, then a final extension step 
at 72 °C for 5 min.  
The PCR products were then purified and sequenced through Sanger 
sequencing at STAB Vida laboratories (Caparica, Portugal) using universal 
bacterial primers 27F and 1492R.  Upon assembly in SeqTrace, all sequences 
were compared to database available from GenBank to identify the most similar  
strain. 
 
2.4- Screening test for antimicrobial activity 
Only isolates that grew in a 24h of period were selected for the antimicrobial 
test screening. Six test agents were used (three Gram positive and three Gram 
negative bacteria): Escherichia coli ATCC 25922, Pseudomonas aeruginosa 
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ATCC 27853, Staphylococcus aureus ATCC 25923, Enterococcus faecalis 
ATCC 29212, Aeromonas salmonicida ATCC 33658 and Bacillus cereus ATCC 
14579. The test agents grew on TSA media, at 37⁰C and at a density of 0.5 
McFarland were inoculated with a cotton swab on a large Petri plate with Mueller 
Hinton agar. After five minutes, 5 µL of the cave bacterial isolates suspensions 
(0.5 McFarland) were inoculated in the same plate in equidistant points. After 24h 
to 48h of incubation, the diameter of the inhibition zone was measured. Tests 
were carried in triplicate at room temperature. 
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3- Results 
3.1- Cultivable bacterial diversity 
A total of 110 bacterial isolates were isolated from the three sampled caves of 
Algarve region. Fifty-two were recovered from Vale do Telheiro cave, forty-two 
from Senhora cave and sixteen from Ibne Ammar cave.  All the bacterial isolates 
are listed in table 1 as well as the corresponding cave of origin, the type of media 
used in the first inoculation, the percentage of query cover, the percentage of 
identity, the sequence length in base pairs and the closest relative strain 
deposited in GenBank. 
Table 1 - List of bacterial isolates of Algarve caves.  
Isolate 
code 
Cave Type of 
cultivation 
media 
Query 
cover 
(%) 
Identity 
(%) 
Sequence 
length (bp) 
Closest relative strain 
(GenBank) 
704 Vale do 
Telheiro 
TSB 100 99 1422 Viridibacillus arvi LMG 
22165 
705 Ibne 
Ammar 
TSB 100 100 1422 Bacillus mobilis MCCC 
1A05942 
706 Senhora TSB 100 99 1424 Bacillus mobilis MCCC 
1A05942 
707 Vale do 
Telheiro 
TSB 100 100 1058 Lysinibacillus 
parviboronicapiens 
NBRC 103144 
708 
 
Vale do 
Telheiro 
TSA 100 99 1406 Bacillus mycoides NBRC 
101228 
709 
 
Vale do 
Telheiro 
TSA 100 97 1150 Lysinibacillus 
parviboronicapiens 
NBRC 103144 
710 
 
Senhora TSA 100 99 1343 Ochrobactrum pecoris 
08RB2639 
712 
 
Senhora 
 
TSA 100 99 1384 Serratia ficaria JCM1241 
713 
 
Vale do 
Telheiro 
TSA 100 99 1419 Brevibacterium 
frigoritolerans DSM 8801 
715 
 
Vale do 
Telheiro 
TSA 100 99 1415 Bacillus mycoides NBRC 
101228 
716 
 
Senhora 
 
TSA 100 98 1394 Viridibacillus arvi LMG 
22165 
718 
 
Senhora 
 
PCA 
 
100 99 1373 Bacillus proteolyticus 
MCCC 1A00365 
720 
 
Vale do 
Telheiro 
PCA 
 
100 99 1405 Paenibacillus lautus 
AB236d 
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721 
 
Vale do 
Telheiro 
PCA 
 
100 99 1416 Paenibacillus 
taichungensis BCRC 
17757 
724 
 
Vale do 
Telheiro 
PCA 100 92 1424 Lysinibacillus 
parviboronicapiens 
NBRC 103144 
725 
 
Vale do 
Telheiro 
TSA 100 99 1421 Bacillus mycoides NBRC 
101228  
728 
 
Vale do 
Telheiro 
TSA 100 99 1422 Bacillus mycoides NBRC 
101228 
729 
 
Vale do 
Telheiro 
TSB 99 99 1345 Lysinibacillus 
parviboronicapiens 
NBRC 103144 
731 
 
Senhora 
 
TSB 100 100 1410 Bacillus mycoides NBRC 
101228 
732 
 
Senhora 
 
TSB 100 100 1383 Bacillus proteolyticus 
MCCC 1A00365 
733 
 
Vale do 
Telheiro 
PCA 100 99 1413 Serratia quinivorans 
4364 
734 
 
Vale do 
Telheiro 
PCA 100 99 1286 Serratia quinivorans 
4364 
740 
 
Ibne 
Ammar 
 
PCA 100 100 1384 Nocardia coeliaca DSM 
44595 
743 
 
Vale do 
Telheiro 
PCA 100 100 1407 Viridibacillus arvi FJAT-
45874 
744 
 
Vale do 
Telheiro 
PCA 100 99 1421 Brevibacterium 
frigoritolerans DSM 8801 
748 
 
Vale do 
Telheiro 
PCA 100 100 1373 Bacillus proteolyticus 
MCCC 1A00365 
750 
 
Vale do 
Telheiro 
PCA 100 100 1424 Bacillus mycoides NBRC 
101228 
752 
 
Vale do 
Telheiro 
PCA 100 100 1389 Bacillus mycoides NBRC 
101228 
753 
 
Vale do 
Telheiro 
TSA 100 99 1391 Pseudomonas brenneri 
CFML 97-391 
754 
 
Vale do 
Telheiro 
TSA 100 99 1402 Pseudomonas 
chlororaphis subsp. 
aurantiaca NCIB 10068 
756 
 
Vale do 
Telheiro 
TSA 100 99 1412 Bacillus mycoides NBRC 
101228 
758 
 
Senhora 
 
PCA 100 99 1385 Paeniglutamicibacter 
kerguelensis KGN15 
760 
 
Senhora 
 
TSA 100 100 1383 Brevibacterium 
frigoritolerans DSM 8801 
30 
 
761 
 
Senhora 
 
TSA 100 99 1416 Bacillus mobilis MCCC 
1A05942 
763 
 
Vale do 
Telheiro 
PCA 100 99 1419 Bacillus wiedmannii FSL 
W8-0169 
764 
 
Vale do 
Telheiro 
PCA 100 99 1357 Rhodococcus jialingiae 
djl-6-2 
765 
 
Vale do 
Telheiro 
PCA 100 99 1328 Achromobacter 
marplatensis B2 
766 
 
Senhora 
 
PCA 100 100 1413 Bacillus wiedmannii FSL 
W8-0169 
767 
 
Senhora 
 
PCA 100 100 1434 Bacillus mycoides NBRC 
101228 16S 
768 
 
Senhora 
 
PCA 100 100 1386 Bacillus wiedmannii FSL 
W8-0169 
769 
 
Senhora 
 
PCA 100 99 1443 Bacillus wiedmannii FSL 
W8-0169 
770 
 
Senhora 
 
PCA 100 99 1439 Bacillus wiedmannii FSL 
W8-0169 
771 
 
Ibne 
Ammar 
TSA 100 99 1418 Bacillus mobilis MCCC 
1A05942 
772 
 
Ibne 
Ammar 
TSA 100 99 1415 Lactococcus taiwanensis 
0905C15 
773 
 
Ibne 
Ammar 
TSA 100 99 1403 Bacillus toyonensis BCT-
7112 
774 
 
Senhora 
 
TSB 100 100 1427 Psychrobacillus 
lasiicapitis NEAU-
3TGS17 
775 
 
Senhora 
 
TSB 100 100 1403 Brevibacterium 
frigoritolerans DSM 8801 
776 
 
Senhora 
 
TSB 100 98 1429 Sporosarcina 
psychrophila NBRC 
15381 
777 
 
Senhora 
 
TSA 100 99 1445 Pseudomonas 
chlororaphis subsp. 
aurantiaca NCIB 1006 
780 
 
Senhora 
 
TSB 100 99 1422 Psychrobacillus 
lasiicapitis NEAU-
3TGS17 
782 
 
Vale do 
Telheiro 
TSA 100 99 1418 Bacillus mycoides NBRC 
101228 
786 
 
Senhora 
 
TSA 100 99 1421 Psychrobacillus 
lasiicapitis NEAU-
3TGS17 
31 
 
787 
 
Vale do 
Telheiro 
TSA 100 99 1409 Psychrobacillus 
lasiicapitis NEAU-
3TGS17 
788 
 
Vale do 
Telheiro 
TSA 100 99 1419 Psychrobacillus 
psychrodurans 68E3 
793 
 
Ibne 
Ammar 
TSA 100 99 1406 Bacillus mycoides NBRC 
101228 
794 
 
Senhora 
 
TSA 100 99 1400 Psychrobacillus 
lasiicapitis NEAU-
3TGS17 
796 
 
Vale do 
Telheiro 
TSA 100 99 1404 Pseudomonas 
chlororaphis subsp. 
aurantiaca NCIB 10068 
797 
 
Vale do 
Telheiro 
TSA 100 99 1420 Bacillus mobilis  MCCC 
1A05942 
798 
 
Vale do 
Telheiro 
TSA 100 99 1405 Bacillus kochii WCC 
4582 
800 Vale do 
Telheiro 
TSA 100 100 1414 Bacillus mycoides NBRC 
101228 
801 
 
Vale do 
Telheiro 
TSA 100 99 1392 Glutamicibacter 
arilaitensis Re117 
802 
 
Vale do 
Telheiro 
PCA 100 99 1383 Serratia grimesii DSM 
30063 
803 
 
Vale do 
Telheiro 
PCA 100 99 1412 Serratia grimesii DSM 
30063 
805 
 
Ibne 
Ammar 
TSA 100 99 1416 Staphylococcus 
edaphicus CCM 8730 
806 
 
Ibne 
Ammar 
TSA 100 99 1402 Lysinibacillus 
contaminans FSt3A 
807 
 
Vale do 
Telheiro 
PCA 100 99 1413 Serratia grimesii DSM 
30063 
808 
 
Vale do 
Telheiro 
PCA 100 99 1429 Serratia grimesii DSM 
30063 
809 
 
Vale do 
Telheiro 
PCA 100 99 1397 Pseudomonas 
helmanticensis OHA11 
810 
 
Vale do 
Telheiro 
TSA 100 100 1416 Bacillus mycoides 1-3T 
812 
 
Vale do 
Telheiro 
TSB 100 100 1403 Bacillus safensis NBRC 
100820  
813 
 
Ibne 
Ammar 
PCA 100 100 1426 Bacillus mycoides NBRC 
101228 
814 
 
Vale do 
Telheiro 
PCA 100 99 1399 Serratia liquefaciens 
ATCC 27592 
816 
 
Ibne 
Ammar 
TSA 100 99 1400 Advenella kashmirensis 
subsp. methylica PK1 
32 
 
861 
 
Senhora 
 
PCA 100 99 1387 Bacillus wiedmannii FSL 
W8-0169 
862 
 
Senhora 
 
PCA 100 99 1356 Bacillus mycoides NBRC 
101228 
863 
 
Senhora 
 
PCA 100 100 1407 Bacillus mycoides NBRC 
101228 
864 
 
Senhora 
 
PCA 100 99 1402 Bacillus mobilis MCCC 
1A05942 
865 
 
Senhora 
 
PCA 100 99 1230 Glutamicibacter 
arilaitensis Re117 
867 
 
Senhora 
 
PCA 100 100 1434 Bacillus mycoides NBRC 
101228 
869 
 
Senhora 
 
TSB 100 100 1404 Bacillus mycoides NBRC 
101228 
871 
 
Ibne 
Ammar 
TSB 100 100 1410 Viridibacillus arvi LMG 
22165 
872 
 
Ibne 
Ammar 
TSA 100 99 1427 Psychrobacillus 
lasiicapitis NEAU-
3TGS17 
873 
 
Ibne 
Ammar 
TSA 100 99 1386 Achromobacter kerstersii 
LMG 3441 
875 
 
Ibne 
Ammar 
TSA 100 99 1389 Achromobacter kerstersii 
LMG 3441 
877 
 
Senhora 
 
TSA 100 99 1411 Stenotrophomonas humi 
R-32729 
878 
 
Senhora 
 
PCA 100 100 1416 Bacillus toyonensis BCT-
7112 
879 
 
Senhora 
 
PCA 100 100 1388 Bacillus wiedmannii FSL 
W8-0169 
880 
 
Senhora 
 
PCA 100 99 1427 Bacillus wiedmannii FSL 
W8-0169 
881 
 
Senhora 
 
PCA 100 98 1311 Lysinibacillus 
parviboronicapiens 
NBRC 103144 
882 
 
Senhora 
 
PCA 100 100 1417 Bacillus mycoides NBRC 
101228 
883 
 
Senhora 
 
TSA 100 100 1420 Bacillus wiedmannii FSL 
W8-0169 
884 
 
Senhora 
 
TSA 100 100 1424 Bacillus mycoides NBRC 
101228 
886 
 
Vale do 
Telheiro 
TSB 100 99 1311 Bacillus proteolyticus 
MCCC 1A00365 
887 
 
Vale do 
Telheiro 
TSB 100 100 1416 Bacillus mycoides NBRC 
101228 
33 
 
888 
 
Ibne 
Ammar 
PCA 100 100 1421 Bacillus mycoides NBRC 
101228 
890 
 
Vale do 
Telheiro 
TSA 100 100 1423 Bacillus toyonensis BCT-
7112 
891 
 
Vale do 
Telheiro 
TSA 100 98 1424 Bacillus simplex LMG 
11160 
892 
 
Senhora 
 
TSB 100 99 1423 Bacillus wiedmannii FSL 
W8-0169 
897 
 
Vale do 
Telheiro 
TSB 100 99 1395 Viridibacillus arvi LMG 
22165 
898 
 
Vale do 
Telheiro 
TSB 100 99 1422 Viridibacillus arvi LMG 
22165 
899 
 
Ibne 
Ammar 
PCA 100 99 1424 Bacillus toyonensis BCT-
7112 
901 
 
Vale do 
Telheiro 
TSA 100 99 1406 Bacillus mobilis MCCC 
1A05942 
902 
 
Vale do 
Telheiro 
TSA 100 100 1410 Viridibacillus arvi LMG 
22165 
904 
 
Vale do 
Telheiro 
TSA 100 99 1386 Bacillus mobilis MCCC 
1A05942 
905 
 
Vale do 
Telheiro 
TSA 100 99 1388 Bacillus mobilis MCCC 
1A05942 
907 
 
Senhora 
 
TSB 100 100 1426 Bacillus mobilis MCCC 
1A05942 
908 
 
Senhora 
 
TSB 100 100 1412 Bacillus toyonensis BCT-
7112 
909 
 
Senhora 
 
TSB 100 99 1318 Bacillus mobilis MCCC 
1A05942 
910 
 
Senhora 
 
TSA 100 100 1418 Bacillus mobilis MCCC 
1A05942 
911 
 
Vale do 
Telheiro 
PCA 100 99 1421 Bacillus proteolyticus 
MCCC1A00365 
 
After 16S gene amplification and sequencing, the bacterial isolates were 
grouped in three different phyla (figure 2): Proteobacteria, Actinobacteria and 
Firmicutes, with dominance of the last in all three caves. 
Not many differences were found in genus distribution between caves. A total 
of 19 genera were recovered (figure 3) from all the three caves, namely 
Achromobacter, Advenella, Bacillus, Brevibacterium, Glutamicibacter, 
Lactococcus, Lysinibacillus, Nocardia, Ochrobactrum, Paenibacillus, 
Paeniglutamicibacter, Pseudomonas, Psychrobacillus, Rhodococcus, Serratia, 
Sporosarcina, Staphylococcus, Sterotrophomonas and Viridibacillus. 
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Representatives of genus Bacillus, Lysinibacillus, Viridibacillus and 
Psychrobacillus were common in all caves.   
From all the sequences analysed it is important to highlight the sequence of 
the bacterial isolate 724, isolated from Vale do Telheiro sample, since only shared 
92% of identity with the closest relative strain Lysinibacillus parviboronicapiens 
strain NBRC 103144. The sequence had 1424 base pairs and 100% in the query 
cover parameter. This result may suggest a possible new species for 
Lysinibacillus genus. 
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34
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Figure 2 - Phyla distribution of bacteria isolated from Vale do Telheiro, Ibne Ammar and Senhora caves. 
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Figure 3 - Genus distribution of bacterial strains according to the cave origin. 
 
3.2- Antimicrobial activity 
Approximately 52% of the isolates revealed antimicrobial activity against at 
least one test agent.  
 
Figure 4 - Example of an antimicrobial test plate with bacterial isolates 807 and 808 showing clear 
inhibition zones. 
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The bacterial isolates with activity belonged to the genera Bacillus, 
Viridibacillus, Psychrobacillus, Serratia and Pseudomonas. 
 
From the total number of strains with antimicrobial activity (figure 6), 81% 
showed antagonistic activity against P. aeruginosa, followed by B. cereus (49%), 
S. aureus (47%) and A. salmonicida (40%) respectively. Only 10% of the isolates 
were active against E. faecalis. Not a single isolate was active against E. coli.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0 10 20 30 40 50 60
Vale do Telheiro
Senhora
Ibne Ammar
Isolates with and without antimicrobial activity isolated from each cave
No. of Isolates with antimicrobial activity Total no. Of isolates
Figure 5 - Antimicrobial activity of bacterial isolates from each cave. 
10,2
47,5
40,7
81,4
49,2
Percentage of isolates with antimicrobial activity against each test agent
E. feacalis S. aureus A. salmonicida P. aeruginosa B. cereus
Figure 6 – Percentage of bacterial isolates with antimicrobial activity against each test agent. 
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 A remarkable antimicrobial activity was registered in the ten isolates listed 
on table 2. These isolates, belonging to genus Pseudomonas and Bacillus, 
showed antimicrobial activity against four or five test agents. Isolates 715, 737, 
754, 796, 799, 761 and 782 showed antagonistic activity against four test agents.  
Isolates 768, 769 and 770 demonstrated a remarkable against five of the six 
test agents. Isolate 796 registered the major inhibition zones against S. aureus 
(19,54 mm), P. aeruginosa (22,43 mm), B. cereus (20,33 mm) and A. salmonicida 
(19,65 mm). 
Table 2 - List of strains with remarkable antimicrobial activity. 
 
ND- Not defined; “-“ – no inhibition zone; “+” – Diameter of the inhibition zone < 15mm; “++” – Diameter of the inhibition 
zone > 15mm. 
 
 
 
 
  
  Antimicrobial activity agent test 
Isolate 
code 
Closest relative 
strain 
E. 
feacalis 
S. 
aureus 
P. 
aeruginosa 
B. 
cereus 
S. 
salmonicida 
715 Bacillus mycoides NBRC 
101228 
- ++ ++ + + 
737 ND ++ - ++ + ++ 
754 Pseudomonas 
chlororaphis subsp. aurantiaca 
NCIB 10068 
- ++ ++ ++ + 
768 Bacillus wiedmannii FSL 
W8-0169 
+ + ++ + + 
769 Bacillus wiedmannii FSL 
W8-0169 
+ + ++ + + 
770 Bacillus wiedmannii FSL 
W8-0169 
+ ++ ++ + + 
796 Pseudomonas 
chlororaphis subsp. aurantiaca 
NCIB 10068 
- ++ ++ ++ ++ 
799 ND - + ++ ++ ++ 
861 Bacillus wiedmannii FSL 
W8-0169 
+ ++ + + - 
882 Bacillus mycoides NBRC 
101228 
+ ++ ++ - + 
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4- Discussion 
Previous studies throughout the world have already demonstrated the potential 
of caves for harbouring a wide bacterial diversity (Ghosh et al. 2017; Belyagoubi 
et al. 2018; Borderie et al. 2016) that could present also a new source of 
molecules with potential bioactivity, namely antimicrobial (Klusaite et al. 2016). 
However, in Portugal, besides the studies already conducted in the Azorean cave 
lava tubes (Hathaway et al. 2014). The most significant cave systems existent in 
the karstic areas, remain unexplored and may represent a valuable asset not only 
in terms of microbial biodiversity, but also as a potential reservoir for new 
molecules with bioactivity.  Indeed our study, focusing only on cultivable bacteria, 
showed that karstic Algarve caves, namely Vale do Telheiro, Senhora and Ibne 
Ammar are inhabited by a great diversity of bacterial groups. Also, using only 
three types of culture media, TSA, PCA and TSB, we were able to isolate 110 
bacterial strains referring to three phyla.  Although the number of isolates wasn’t 
really low, the number could be higher if we had employed a poor nutrient media 
like R2A (Yasir 2018).  
The cultured diversity of Algarve caves is dominated by Firmicutes. Our results 
are in accordance with a previous study performed in Kartchner Caverns (Ikner 
et al. 2007). In this study Firmicutes were the most represented groups in both 
touristic and non-touristic impacted areas (Ikner et al. 2007) . Members of the 
phylum Firmicutes are characterized by a wide range of metabolic capabilities 
being able to process complex or simple forms of organic compounds. Also, this 
group is commonly found under extreme conditions like dehydration and nutrient 
stress (Slepecky and Hemphill 1986). Members of the genus Bacillus, the most 
represented genus, are also able to produce endospores, a resistance strategy 
to survive adverse conditions (Tomczyk-Żak and Zielenkiewicz 2016). However, 
the dominance of Firmicutes is not supported by other studies (Aminov 2010; 
Sarbu, Kane, and Kinkle 1996; Diana E. Northup et al. 2003). For example, in 
Magura Cave the percentage of Firmicutes was only 6,5% and Proteobacteria 
was the dominant phyla with 63% (Tomova et al. 2013). In addition, isolate 724 
shared only 92% identity with the closest relative strain Lysinibacillus 
parviboronicapiens strain NBRC 103144 (Miwa et al. 2009). The genus was 
recently proposed (Ahmed et al. 2007) and the type species of the genus is 
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Lysinibacillus boronitolerans, and its other members are Lysinibacillus 
sphaericus and Lysinibacillus fusiformis. This result reinforces the idea that caves 
may provide novel species increasing the possibility of finding also new 
molecules. 
Proteobacteria were the second largest groups found in Algarve caves. 
Bacteria belonging to this phylum are dominant in Wind cave (Chelius and Moore 
2004), Tito Bustilo cave (Schabereiter-Gurtner et al. 2002) but also on microbial 
mats of lava caves (D.E. Northup et al. 2011). Like Firmicutes, they can process 
a wide range of nutrients, being however unable to endure severe nutrient stress 
(Engel 2010). Presumably, the success of Proteobacteria in subterranean 
environments could be related to the presence of some insects or organic input 
via superficial waters infiltration (Tomczyk-Zak and Zielenkiewicz 2015). 
Actinobacteria isolated from Algarve caves are represented by genus 
Nocardia, Rhodococcus, Brevibacterium, Glutamicibacter and 
Paeniglutamicibacter. Nocardia and Rhodococcus genus are related to 
degradation of organic matter and decomposition of hazardous chemical 
compounds (Groth et al. 1999). Bacteria belonging to this phylum often dominate 
soils microbiota but in subterranean environments they can also be encountered 
in rock walls and speleothems like stalactites and stalagmites. Some authors 
believe that members of Actinobacteria are involved in biomineralization 
processes being, in part, responsible for cave shaping (Cañveras et al. 2001; 
Jones 2001).  
With regard to the antimicrobial capacity of bacteria isolated from Algarve 
caves, the results showed that more than half of the isolates had antagonistic 
activity against one of agent tests. Prospection of antimicrobial compounds on 
less studied and extreme environments have already revealed to be a good 
approach to increase antimicrobials discovery (Arifuzzaman, Khatun, and 
Rahman 2010; Kay, Pathom-Aree, and Cheeptham 2013; Subramani and 
Aalbersberg 2013). Although Actinobacteria is a highly prolific bacterial group 
with about 55% of the existing antimicrobial compounds isolated from the 
Streptomyces genus and 11% from other genera (Hopwood 2007), in our study 
none of the isolates belonging to this phyla showed antimicrobial capacity against 
any of test agents. On the other hand, Firmicutes and Proteobacteria, revealed 
the most promising antimicrobial properties with genus Bacillus and 
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Pseudomonas, respectively. Some studies reported antimicrobial activity of 
Pseudomonas species  (Cardozo et al. 2013) and some already isolated the 
substance responsible for the activity, namely zafrin [4b-methyl-5, 6, 7, 8 
tetrahydro-1 (4b-H)- phenanthrenone (Uzair et al. 2008). Bacillus species are 
well-known producers of a wide range of antimicrobial compounds, including 
peptides, lantibiotics and other bacteriocins (Abriouel et al. 2011). Also, 
antimicrobials produced by members of the genus Bacillus are more active 
against Gram-positive bacteria (Slepecky and Hemphill 1986). Further analysis 
should be performed in order to isolate and characterize the antimicrobials 
produced by these strains, contributing to the discovery of novel antibiotics. In 
addition, and considering the potential already observed in other studies and 
reviewed by Gosh and co-workers (2017), the bioactivity assessment should go 
beyond antimicrobial activity and also encompass activities such as the 
antitumoral. 
Overall this study contributes for the knowledge of Portuguese cultivable cave 
bacterial diversity, being to our knowledge, the first being performed on the 
Algarve karstic region. Furthermore, this work also reinforces the idea that 
prospection of new antimicrobial compounds in subterranean environments is a 
promising approach in order to fight spreading of antimicrobial resistance 
problem. 
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1- Final Remarks 
On a global perspective, the work carried out in this dissertation intended to 
contribute for the generalised effort of searching new potential sources of 
antibiotics. By developing this work, we were able to contribute for two specific 
aims: i) perform the first prospection of bacteria with antimicrobial activity in 
Algarve’s karstic caves and ii) contribute to the filling the existent knowledge gap 
concerning Portuguese caves’ microbial diversity, namely focusing on cultivable 
bacteria. 
In order to achieve the proposed goals, three Algarve karstic caves were 
sampled namely Vale do Telheiro, Ibne Ammar and Senhora caves. This choice 
resulted from the fact that caves are oligotrophic environments with no light and 
high humidity levels and that in the selected caves had never been prospected. 
In fact, the choice of the sampling sites reflected a current trend for prospecting 
new bacteria and possibly new compounds in extreme habitats (Axenoy-
Gribanov et al. 2016; Selama et al.2014). The bacterial isolates from the caves 
were obtained using common microbiological media and, as a result from the 
antimicrobial screening, we observed that 53% of the bacterial isolates were 
capable of inhibiting the growth of at least one test agent. This evidence 
contributes for the reinforcement of the idea that caves have a great potential for 
harbouring many bacterial species able to produce antimicrobial compounds 
(Axenov-Gribanov et al. 2016; Jiang et al. 2015; Herold et al. 2005). The strains 
with activity belonged to the genus Viridibacillus, Psychrobacillus, Serratia, 
Pseudomonas and and Bacillus, with the latter encompassing the isolates with 
the most tests agents, both Gram positive and Gram negative. It would be 
interesting to further assess the bioactivity of the compounds produced by these 
bacteria, both towards other pathogenic bacteria as test agents, and also their 
potential as antitumoral compounds. As shown by Selama et al. (2014) bacteria 
strains from extreme habitats may present both of these bioactivities.  
From a bacteria diversity point of view, our strategy provided the isolation of 
110 bacterial isolates from the three caves. After phylogenetical analysis, the 
bacterial isolates were affiliated to three bacterial phyla: Firmicutes, 
Proteobacteria and Actinobacteria. In general, the cultivable bacteria diversity 
was similar between the caves, being grouped in a total of 19 genera. These 
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results might be the consequence of the restricted number of culture media 
employed in this study. Also, the use of other media, or supplements, can be a 
valuable addition in further studies in order to obtain other bacterial groups. 
Furthermore, a dereplication should be applied to eliminate identical strains. 
Other strategy that could favour our findings can be to simulate in the laboratory 
the subterranean environment: absence of natural light, controlled temperatures 
from 10 to 12 Celsius degrees and air humidity of 98-100% during the incubation 
period. Furthermore, longer incubation periods, could also be beneficial for the 
isolation of slow-growth bacterial strains. 
Considering the results obtained in this dissertation, further studies should be 
performed, including testing the bacterial supernatants of the most active strains 
and optimizing the culture conditions (temperature, pH, broth media) to increase 
the production of the antimicrobial compounds responsible for the activity 
observed in our antagonistic tests. Furthermore, chemical analysis of the extracts 
should be performed in order to isolate the antimicrobial compound and elucidate 
about his structure.  
Overall, subterranean environments should be further studied, firstly to 
evaluate the diversity of microorganisms that occur there, secondly to understand 
their role in caves’ ecosystem and lastly to assess and extract bioactive 
compounds produced by these microorganisms in order to suppress the current 
demand for these compounds, namely antibiotics. 
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